<h1 id="blood-transfusion">Blood transfusion</h1>

<p><strong>Blood transfusion</strong> .</p>

<p>Risks: Massive transfusion (blood volume replaced in &lt;24h): ↓ Temp, ↓
pH, ↓ coagulation factors, ↓ Ca++, ↑K+.</p>

<p>In order of morbidity/mortality:</p>

<ol>
  <li>
    <p>TRALI</p>
  </li>
  <li>
    <p>Immediate haemolytic reactions: immune/non-immune - Intravascular
haemolysis: fever, urticaria, hypotension, DIC.</p>
  </li>
  <li>
    <p>Delayed haemolytic reactions 7-21 days, extravascular haemolysis, ↓
Hb.</p>
  </li>
  <li>
    <p>Fever reaction. Common but harmless.</p>
  </li>
  <li>
    <p>Allergy. Urticaria, fever. Anaphylaxis rare.</p>
  </li>
  <li>
    <p>Infection:</p>
  </li>
</ol>

<p>Bacterial</p>

<p>- RCC (4°C) Gram -ve, eg. Yersinia enterocolitica; Pseudomonas</p>

<p>- Plts (20°C) Gram +ve, eg. Staph. Epidermidis, Staph. Aureus,
Bacillus.</p>

<p>Viral</p>

<p>- HBV</p>

<p>- HCV: 1 in 32 million</p>

<p>- HIV: 1 in 5 million</p>

<p>- CMV</p>

<p>Prion</p>

<ol>
  <li>
    <p>GvHD. Pre-leucodepletion. Mortality 90%.</p>
  </li>
  <li>
    <p>Immunosuppression - used therapeutically to prevent transplant
rejection.</p>
  </li>
</ol>

<p>[Maxwell, M.J. et al. <em>Contin Educ Anaesth Crit Care Pain</em> <strong>6</strong> ,
225-229(2006).]</p>
